Mass Spectrometry in Drug Metabolism and Pharmacokinetics 2008
DOI: 10.1002/9780470409817.ch2
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative Bioanalysis in Drug Discovery and Development: Principles and Applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 49 publications
0
2
0
Order By: Relevance
“…The off-line methods all provided appropriate levels of sensitivity for the intended purpose. This reflects the improvement in mass spectrometer sensitivity through technological advances in recent years which has meant that in general, pharmacokinetic analysis in drug discovery and development can be readily achieved using available technologies [9].…”
Section: Discussionmentioning
confidence: 99%
“…The off-line methods all provided appropriate levels of sensitivity for the intended purpose. This reflects the improvement in mass spectrometer sensitivity through technological advances in recent years which has meant that in general, pharmacokinetic analysis in drug discovery and development can be readily achieved using available technologies [9].…”
Section: Discussionmentioning
confidence: 99%
“…In order to overcome this resistance, the combination of ceftazidime with the β-lactamase inhibitor avibactam is currently being developed. 4 It is accepted that stable isotopically labeled compounds are the 'gold standard' 5,6 internal standards for use in quantitative bioanalysis and can be more successful in correcting for matrix effects in mass spectrometry assays than structural analogs. 7 For this reason, stable isotope-labeled ceftazidime was required to support ongoing clinical studies.…”
Section: Introductionmentioning
confidence: 99%